NASDAQ:PALI

Palisade Bio (PALI) News Today

$0.72

-1.22 (-62.77%)

(As of 08/9/2023 ET)

Compare

Today's Range: $0.60
▼
$0.74
50-Day Range: $1.32
▼
$2.31
52-Week Range: $0.60
▼
$19.99

Volume: 4.29 million shs
Average Volume: 1.04 million shs
Market Capitalization: $4.85 million

P/E Ratio: 0.14
Dividend Yield: N/A
Price Target: $16.00

Source

Source	Headline
	Palisade Bio, Inc.: Palisade Bio Announces Topline Results from U.S. Phase 2 PROFILE Study Evaluating LB1148 for Post-Surgical Abdominal Adhesions finanznachrichten.de - August 9 at 2:41 PM
	Palisade Bio Shares Sink After Trial Misses Primary Endpoint marketwatch.com - August 9 at 2:41 PM
	Why Is Palisade Bio Stock Sinking Today? msn.com - August 9 at 2:41 PM
	Palisade Bio's Post-Surgery Treatment Trial Misses Primary Endpoint marketwatch.com - August 9 at 9:41 AM
	marketbeat.com - August 9 at 8:05 AM
	PALI - Palisade Bio, Inc. finance.yahoo.com - August 7 at 1:05 PM
	Palisade Bio Announces Completion of Enrollment in LB1148 Dose Optimization Study finance.yahoo.com - July 5 at 12:33 PM
	PALISADES ANNOUNCES NEW FOUND MAKES NEW HIGH-GRADE, AT SURFACE DISCOVERY AT JACKPOT ZONE AT QUEENSWAY PROJECT finance.yahoo.com - June 22 at 9:46 AM
	Palisade Bio Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest finance.yahoo.com - June 14 at 9:54 AM
	Palisade Bio, Inc.: Palisade Bio Promotes J.D. Finley to Chief Executive Officer finanznachrichten.de - June 1 at 12:57 PM
	Palisade Bio appoints J.D. Finley as permanent CEO msn.com - June 1 at 12:57 PM
	Palisade Bio Promotes J.D. Finley to Chief Executive Officer finance.yahoo.com - June 1 at 12:57 PM
	Palisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts finance.yahoo.com - May 24 at 9:55 AM
	Palisade Bio, Inc. (PALI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now msn.com - May 23 at 2:32 PM
	Ladenburg Thalmann Maintains Buy on Palisade Bio, Lowers Price Target to $16 benzinga.com - May 18 at 9:59 AM
	PALISADES ANNOUNCES NEW FOUND GOLD INTERCEPTS AT KEATS WEST finance.yahoo.com - May 17 at 8:56 AM
	Ladenburg Thalmann Maintains Palisade Bio (PALI) Buy Recommendation msn.com - May 17 at 3:56 AM
	Maxim Group Keeps Their Buy Rating on Palisade Bio (PALI) markets.businessinsider.com - May 13 at 12:34 PM
	Palisade Bio, Inc.: Palisade Bio Reports First Quarter 2023 Financial Results finanznachrichten.de - May 12 at 9:33 PM
	Palisade Bio Reports First Quarter 2023 Financial Results finance.yahoo.com - May 12 at 8:52 AM
	Palisade Bio Announces Enrollment and Dosing of First Patient in LB1148 Dose Optimization Study finance.yahoo.com - May 11 at 12:51 PM
	S-1: PALISADE BIO, INC. marketwatch.com - April 22 at 4:54 PM
	Palisade Bio, Inc. (PALI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? finance.yahoo.com - April 17 at 4:00 PM
	Premarket Mover: Palisade Bio Inc (PALI) Up 0.96% benzinga.com - April 12 at 10:01 PM
	Palisade (PALI) Enrolls First Patient in LB1148 Study in China msn.com - April 6 at 8:09 PM
	Palisade Bio Receives Canadian Patent Covering Composition of Lead Program in Development, LB1148 finance.yahoo.com - April 6 at 10:08 AM
	Palisade Bio Shares Rise After First Patient Dosed With Gastrointestinal Drug marketwatch.com - April 5 at 7:22 PM
	Palisade Bio, Inc.: Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148 finanznachrichten.de - April 5 at 2:22 PM
	Palisade Bio shares plummet following a $6M registered direct offering seekingalpha.com - April 5 at 9:21 AM
	Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148 finance.yahoo.com - April 5 at 9:21 AM
	Palisade Bio Shares Down for a Second Day, Declining 10% marketwatch.com - April 4 at 1:01 PM
	Palisade Bio's Shares Drop 35% After $6 Million Direct Offering Prices marketwatch.com - April 3 at 4:59 PM
	Why Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket msn.com - April 3 at 11:58 AM
	Why Palisade Bio (PALI) Stock Is Diving 30% Lower msn.com - April 3 at 11:58 AM
	Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules finance.yahoo.com - April 3 at 11:58 AM
	Why Is Palisade Bio (PALI) Stock Up 36% Today? investorplace.com - March 31 at 9:08 AM
	'What Makes Palisade Bio, Inc. A New Buy Stock' - Zacks Research benzinga.com - March 31 at 4:41 AM
	Maxim Group Upgrades Palisade Bio (PALI) msn.com - March 30 at 10:29 PM
	Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 msn.com - March 30 at 12:28 PM
	Palisade Bio shares are trading higher after Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target. benzinga.com - March 30 at 12:28 PM
	What Makes Palisade Bio, Inc. (PALI) a New Buy Stock finance.yahoo.com - March 29 at 6:31 PM
	Palisade Bio, Inc.: Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update finanznachrichten.de - March 23 at 1:04 PM
	Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update finance.yahoo.com - March 23 at 1:04 PM
	Rich Lister’s $100m investment in ‘huge commercial opportunity’ afr.com - March 21 at 5:28 PM
	PALISADES ANNOUNCES NEW FOUND'S INCREASED WEIGHTING BY GDXJ finance.yahoo.com - March 15 at 12:00 PM
	Palisade rises on upcoming EU patent linked to LB1148 for post-surgical abdominal adhesions msn.com - March 1 at 1:40 PM
	Palisade Bio Receives Intention to Grant from European Patent Office for LB1148 Patent finance.yahoo.com - March 1 at 1:40 PM
	Palisade Bio Promotes Robert McRae to Chief Operating Officer finance.yahoo.com - February 8 at 10:21 AM
	PALI Palisade Bio, Inc. seekingalpha.com - January 21 at 6:46 PM
	Palisade Bio Further Strengthens Balance Sheet with Early Exercise of Warrants Resulting in Cash Proceeds of $4.9 Million finance.yahoo.com - January 10 at 12:42 PM

Get Palisade Bio News Delivered to You Automatically

PALI Media Mentions By Week

PALI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PALI
News Sentiment
▼
-0.29

0.42
▲
Average
Medical
News Sentiment

PALI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PALI Articles
This Week
▼
7

1
▲
PALI Articles
Average Week

Get Palisade Bio News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:PALI) was last updated on 8/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Palisade Bio (PALI) News Today

PALI Media Mentions By Week

PALI Media Sentiment

PALI News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info